Related Experiment Video
Updated: Jul 5, 2026

Multilevel Microdissection and Functional-Structural Profiling of Human Renal Arterial Branches
Published on: September 5, 2025
Arterial structure and function in end-stage renal disease
Alain P Guérin1, Bruno Pannier, Sylvain J Marchais
1Hôpital Manhès, 8 rue Roger Clavier, Fleury-Mérogis, 91712, France.
Insights
Patients with end-stage renal disease (ESRD) experience rapid macrovascular disease, leading to significant cardiovascular complications. Arterial stiffening, driven by calcifications, contributes to these adverse outcomes beyond typical atherosclerosis.
Area of Science:
- Nephrology
- Cardiology
- Vascular Biology
Background:
- Cardiovascular disease (CVD) is a primary cause of death in end-stage renal disease (ESRD) patients.
- Macrovascular complications like left ventricular hypertrophy and ischemic heart disease are prevalent in ESRD.
- Atherosclerosis is a key contributor, but arterial alterations in ESRD are more complex.
Purpose of the Study:
- To explore the spectrum of arterial alterations in ESRD beyond atherosclerosis.
- To investigate the role of nonatheromatous remodeling and arterial stiffening in ESRD pathophysiology.
- To identify factors contributing to arterial stiffening in ESRD.
Main Methods:
- Review of existing literature on arterial changes in ESRD patients.
- Analysis of pathological and physiological mechanisms underlying vascular complications.
- Correlation of arterial stiffening with metabolic and hemodynamic factors.
Main Results:
- ESRD involves a broad range of arterial changes, including large artery remodeling and altered viscoelastic properties.
- Nonatheromatous remodeling and arterial stiffening significantly impair arterial dampening function.
- Arterial stiffening in ESRD is multifactorial, with arterial calcifications being a major contributing factor.
Conclusions:
- Arterial stiffening and nonatheromatous remodeling are critical components of cardiovascular morbidity in ESRD.
- Understanding these broader arterial alterations is crucial for managing CVD in ESRD patients.
- Targeting factors like arterial calcification may mitigate cardiovascular risk in ESRD.
Abstract:
Cardiovascular disease is a major cause of morbidity and mortality in patients with end-stage renal disease (ESRD). Macrovascular disease develops rapidly in ESRD patients and is responsible for the high incidence of left ventricular hypertrophy, ischemic heart disease, cerebrovascular accidents, and peripheral artery diseases. Occlusive lesions due to atheromatous plaques frequently cause these complications; however, atherosclerosis represents only one form of structural response to metabolic and hemodynamic alterations interfering with the "natural" process of aging. The spectrum of arterial alterations in ESRD is broader, including large artery remodeling, changes in viscoelastic properties, and stiffening of arterial walls. Nonatheromatous remodeling principally changes the dampening function of arteries, characterized by stiffening of arterial walls and with deleterious effects on the left ventricle and coronary perfusion. The origin of arterial stiffening in ESRD patients is multifactorial, with extensive arterial calcifications as an important covariate.
Related Concept Videos
Hemodialysis I: Introduction
Blood and Nerve Supply to the Kidney
Bloody Supply to the Kidneys:
The kidneys receive their blood supply from the renal arteries, which branch off from the abdominal aorta—the main artery supplying the abdomen and lower body. The renal arteries enter the kidneys at the hilum, a notch on the medial side of each...
Kidney Structure
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...
Chronic Kidney Disease I: Introduction
Diabetic Nephropathy
